CI 最新10-Q变化

相对上期新增的文字 · 来源:10-Q · 2026-07-30

• (In millions)Pre-taxAfter-taxPre-taxAfter-taxPre-taxAfter-taxPre-taxAfter-tax

• Premiums increased 8% for the three months ended, primarily driven by higher premium rates within Cigna Healthcare, and decreased 10% for the six months ended, primarily driven by the impact of the HCSC transaction (defined in the "Segment Reporting" section) (-17%), offset primarily by higher premi…

• Fees and other revenues increased 6% for the three months ended, primarily reflecting growth in fee-based services within Cigna Healthcare, and increased 10% for the six months ended, primarily reflecting growth in fee-based services within Evernorth Health Services.

• Net investment income for the three months ended increased 15% due to strong returns on real estate investments and securities partnerships. Net investment income for the six months ended was flat, with the stronger returns on real estate investments and securities partnerships in the second quarter…

• Medical costs and other benefit expenses increased 9% for the three months ended, primarily reflecting higher medical costs within Cigna Healthcare, and decreased 10% for the six months ended, primarily driven by the impact of the HCSC transaction (-18%), offset primarily by higher medical costs wit…

相对上期删除的文字 · 来源:10-Q · 2026-04-30

• Selling, general and administrative expenses3,722 4,213 (12)

• Amortization of acquired intangible assets1.48 1.19 1.54 1.23

• Premiums decreased 23%, primarily driven by the impact of the HCSC transaction (defined in the "Segment Reporting" section) (-30%), offset primarily by higher premium rates within our ongoing U.S. Healthcare businesses.

• Fees and other revenues increased 14%, primarily reflecting growth in fee-based services within our Pharmacy Benefit Services operating segment.

• Net investment income decreased 15%, primarily due to lower average assets, due to the impact of the HCSC transaction.

相对上期新增的文字 · 来源:10-Q · 2026-07-30

• 2.On June 2, 2026, Everett Neville, Executive Vice President and Special Advisor to the Chief Executive Officer of The Cigna Group, adopted a 10b5-1 plan. Mr. Neville's plan provides for the sale of up to 1,234 shares of The Cigna Group common stock through March 2, 2027.

• These trading plans were entered into during an open insider trading window and are intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Securities Exchange Act of 1934 and the Company's policies regarding insider transactions.

相对上期删除的文字 · 来源:10-Q · 2026-04-30

• This trading plan was entered into during an open insider trading window and is intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Securities Exchange Act of 1934 and the Company's policies regarding insider transactions.